| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | – | – | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $122.00M | $128.19M | $131.65M | $118.95M | $86.43M |
| R&D | $90.43M | $96.74M | $96.77M | $90.90M | $63.41M |
| SG&A | $31.57M | $31.45M | $34.88M | $28.06M | $23.02M |
| Operating Income | -$122.00M | -$128.19M | -$131.65M | -$118.95M | -$86.43M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$104.08M | -$108.79M | -$117.50M | -$113.84M | -$86.08M |
| EPS (basic) | -1.4100 | -1.6000 | -2.4000 | -2.6100 | -2.6200 |
| EPS (diluted) | -1.4100 | -1.6000 | -2.4000 | -2.6100 | -2.6200 |
| Shares (diluted) | $73.99M | $67.87M | $49.01M | $43.63M | $32.86M |